13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13G Filed 2026-09-18 Event — SEC 0002103370-26-000003 →

MJL Manager LLC → Xenetic Biosciences, Inc. XBIO

Stake: — Shares: — CUSIP: 984015602 Class: Common Stock, $0.001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
3 13D/G filings on this issuer
2 other filings besides this one
Filer Track Record
2 filings by this filer
1 other filing in the data moat
Short Interest · settle 2026-09-30
DTC 1.00
12,868 shares short · -42.7% vs prior

Other 13D/G Filings on Xenetic Biosciences, Inc.

FiledFormFilerStakeShares
2024-03-18 SC CLS Therapeutics, LLC — — view →
2019-10-23 SC Opko Health, Inc. — — view →

Other Filings by MJL Manager LLC

FiledFormIssuerStakeShares
2026-06-25 SCHEDULE 13G SOLIGENIX, INC. SNGX — — view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →